220 results on '"Gutschner, Tony"'
Search Results
2. NANOS1 restricts oral cancer cell motility and TGF-ß signaling
3. Going only half the way: cell cycle exit after the G1 restriction point
4. Correction: Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
5. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer
6. Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases
7. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.
8. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer
9. Chemical Modifications and Their Role in Long Non-coding RNAs
10. NEAT1 promotes genome stability via m6A methylation-dependent regulation of CHD4
11. RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing
12. Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
13. MALAT1: a therapeutic candidate for a broad spectrum of vascular and cardiorenal complications
14. Supplementary Methods, Figures 1 - 4, Tables 2 - 6 from The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
15. Data Supplement from The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF
16. Supplementary Table 1 from The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
17. Data from The Noncoding RNA MALAT1 Is a Critical Regulator of the Metastasis Phenotype of Lung Cancer Cells
18. Data from The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF
19. From biomarkers to therapeutic targets—the promises and perils of long non-coding RNAs in cancer
20. NEAT1 promotes genome stability via m6A methylation-dependent regulation of CHD4
21. RNA therapeutics
22. RNA therapeutics
23. Long Noncoding RNA Function and Expression in Cancer
24. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal
25. Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases
26. Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
27. The Cohesin Complex and Its Interplay with Non-Coding RNAs
28. MALAT1 — a paradigm for long noncoding RNA function in cancer
29. Silencing Long Noncoding RNAs with Genome-Editing Tools
30. Additional file 3 of Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
31. Additional file 8 of Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
32. Additional file 1 of Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
33. Additional file 4 of Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
34. Additional file 6 of Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
35. Additional file 2 of Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
36. Additional file 7 of Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
37. Additional file 5 of Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation
38. Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is an Important Protumorigenic Factor in Hepatocellular Carcinoma
39. Identification of a heat-inducible novel nuclear body containing the long noncoding RNA MALAT1
40. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1)
41. Long Noncoding RNA Function and Expression in Cancer
42. 9p21 Loss Defines the Evolutionary Patterns of Aggressive Renal Cell Carcinomas
43. Post-Transcriptional Expression Control in Platelet Biogenesis and Function
44. RNA-Binding Proteins as Regulators of Migration, Invasion and Metastasis in Oral Squamous Cell Carcinoma
45. Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer
46. LINC00261 Is Differentially Expressed in Pancreatic Cancer Subtypes and Regulates a Pro-Epithelial Cell Identity
47. Increased Level of Long Non-Coding RNA MALAT1 Is a Common Feature of Amoeboid Invasion
48. MALAT1: a therapeutic candidate for a broad spectrum of vascular and cardiorenal complications
49. Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention
50. Evaluation of fluorescence in situ hybridization techniques to study long non-coding RNA expression in cultured cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.